Alzheimer's Disease Trial, Recruiting NCT05950607 Sponsor: Hebrew SeniorLife Condition: Alzheimer's Disease
Back to Alzheimers Disease

Alzheimer's Disease Trial, Recruiting

NCT05950607
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are older than 60 years of age
  • People who have been diagnosed with dementia (any type)
  • People who have a cognitive impairment score greater than "None" on a scale used to measure thinking and memory abilities (confirm with trial site)
  • People who have been living in a nursing home for more than 90 days

Who may not be able to join:

  • People who are 60 years of age or younger
  • People who have been living in a nursing home for fewer than 90 days
  • People who do not have a diagnosis of dementia
  • People whose cognitive impairment score falls into the lowest category ("None") on the scale used by the trial to measure thinking and memory abilities (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Susan Mitchell, MD, MPH, Hebrew SeniorLife

Phone: 16172813669

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Hebrew SeniorLife
Registry
ClinicalTrials.gov
Start date
13 November 2023
Est. completion
30 June 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Antimicrobial use in residents with moderate to advanced dementia

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov